Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery

Methods. This prospective US multicenter trial of leuprolide acetate 1-month depot (7.5–15 mg) for central precocious puberty utilized an open-label treatment period, long-term follow-up, and adult callback. Forty-nine females <9 years old with Tanner breast stage ≥2 before 8 years and 6 males &l...

Descripción completa

Detalles Bibliográficos
Autores principales: Neely, E. Kirk, Lee, Peter A., Bloch, Clifford A., Larsen, Lois, Yang, Di, Mattia-Goldberg, Cynthia, Chwalisz, Kristof
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062984/
https://www.ncbi.nlm.nih.gov/pubmed/21437000
http://dx.doi.org/10.1155/2010/398639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062984/
https://www.ncbi.nlm.nih.gov/pubmed/21437000
http://dx.doi.org/10.1155/2010/398639

Ejemplares similares